- Home
- AZZ vs INDV Comparison
AZZ vs INDV Comparison
Compare AZZ & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZZ | INDV |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AZZ | INDV |
|---|---|---|
| Price | $135.87 | $36.91 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $141.80 | N/A |
| AVG Volume (30 Days) | 174.0K | ★ 2.0M |
| Earning Date | 04-22-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | 486.59 | ★ 8100.00 |
| EPS | ★ 10.50 | 0.69 |
| Revenue | $1,061,817,000.00 | ★ $1,239,000,000.00 |
| Revenue This Year | $7.03 | N/A |
| Revenue Next Year | $4.25 | N/A |
| P/E Ratio | ★ $13.34 | $52.93 |
| Revenue Growth | ★ 14.53 | 4.29 |
| 52 Week Low | $86.67 | $11.08 |
| 52 Week High | $151.67 | $41.00 |
Technical Indicators
Market Signals| Indicator | AZZ | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 54.79 |
| Support Level | $131.60 | $34.91 |
| Resistance Level | $140.60 | $37.83 |
| Average True Range (ATR) | 4.11 | 1.57 |
| MACD | -1.35 | -0.35 |
| Stochastic Oscillator | 7.93 | 32.54 |
Price Performance
Historical ComparisonAbout AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of AZZ Metal Coatings, AZZ Precoat Metals, and AZZ Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company operates in the United States and Canada.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).